Paper6519151
Pharmacokinetics of canrenone and metabolites after base hydrolysis following single and multiple dose oral administration of spironolactone.
Ho PC and 3 others. Eur J Clin Pharmacol, 1984. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetics of canrenone and metabolites after base hydrolysis following single and multiple dose oral administration of spironolactone. Papers, record 6519151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6519151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacokinetics of canrenone and metabolites after base hydrolysis following single and multiple dose oral administration of spironolactone.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Canrenone | Major topic |
| Pregnadienes | Major topic |
| Spironolactone | Major topic |
| Administration, Oral | |
| Adult | |
| Biotransformation | |
| Chromatography, High Pressure Liquid | |
| Female | |
| Humans | |
| Hydrolysis | |
| Kinetics | |
| Male | |
| Spectrometry, Fluorescence |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 894500 | Simultaneous automated determination of spironolactone metabolites in serum. | J Pharm Sci | 1977 | https://conductscience.org/library/papers/894500 | PubMed |
| 2 | 6886998 | Estimating the accumulation of drugs. | J Pharm Sci | 1983 | https://conductscience.org/library/papers/6886998 | PubMed |
| 3 | 4712657 | Pharmacokinetics of spironolactone, canrenone and canrenoate-K in humans. | J Pharmacol Exp Ther | 1973 | https://conductscience.org/library/papers/4712657 | PubMed |
| 4 | 856602 | Disposition kinetics of spironolactone in hepatic failure after single doses and prolonged treatment. | Eur J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/856602 | PubMed |
| 5 | 7329203 | Conversion of spironolactone to an active metabolite in target tissues: formation of 7 alpha-thiospironolactone by microsomal preparations from guinea pig liver, adrenals, kidneys, and testes. | Life Sci | 1981 | https://conductscience.org/library/papers/7329203 | PubMed |
| 6 | 38071 | Re-evaluation of the antimineralocorticoid effect of the spironolactone metabolite, canrenone, from plasma concentrations determined by a new high-pressure liquid-chromatographic method. | Drug Metab Dispos | 1979 | https://conductscience.org/library/papers/38071 | PubMed |
| 7 | 1261155 | Spironolactone. III. Canrenone--maximum and minimum steady-state plasma levels. | Clin Pharmacol Ther | 1976 | https://conductscience.org/library/papers/1261155 | PubMed |
| 8 | 1012347 | Pharmacokinetics of spironolactone in man. | Naunyn Schmiedebergs Arch Pharmacol | 1976 | https://conductscience.org/library/papers/1012347 | PubMed |
| 9 | 858213 | Spironolactone and canrenoate-K: relative potency at steady state. | Clin Pharmacol Ther | 1977 | https://conductscience.org/library/papers/858213 | PubMed |
| 10 | 5044814 | Fluorometric microassay for spironolactone and its metabolites in biological fluids. | J Pharm Sci | 1972 | https://conductscience.org/library/papers/5044814 | PubMed |
| 11 | 973942 | Antagonism of fludrocortisone by spironolactone and canrenone. | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/973942 | PubMed |
| 12 | 6831747 | Pharmacokinetics of spironolactone after a single dose: evaluation of the true canrenone serum concentrations during 24 hours. | Clin Exp Hypertens A | 1983 | https://conductscience.org/library/papers/6831747 | PubMed |
| 13 | 1261154 | Spironolactone. II. Bioavailability. | Clin Pharmacol Ther | 1976 | https://conductscience.org/library/papers/1261154 | PubMed |
| 14 | 780038 | Spironolactone and potassium canrenoate in normal man. | Clin Pharmacol Ther | 1976 | https://conductscience.org/library/papers/780038 | PubMed |
| 15 | 1261153 | Spironolactone. I. Disposition and metabolism. | Clin Pharmacol Ther | 1976 | https://conductscience.org/library/papers/1261153 | PubMed |
| 16 | 872489 | Enhancement by food of canrenone bioavailability from spironolactone. | Clin Pharmacol Ther | 1977 | https://conductscience.org/library/papers/872489 | PubMed |
| 17 | 22216502 | Canrenone--the principal active metabolite of spironolactone? | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/22216502 | PubMed |
| 18 | 363379 | Spironolactone: disposition, metabolism, pharmacodynamics, and bioavailability. | Drug Metab Rev | 1978 | https://conductscience.org/library/papers/363379 | PubMed |
| 19 | 4853286 | Multiple dose kinetics of spironolactone and canrenoate-potassium in cardiac and hepatic failure. | Eur J Clin Pharmacol | 1974 | https://conductscience.org/library/papers/4853286 | PubMed |
| 20 | 7130430 | Effect of micronization on the bioavailability and pharmacologic activity of spironolactone. | J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7130430 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42196253 | Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: Clinical Evidence, Pharmacology, and Drug-Drug Interactions for Personalized Management of Hyperkalemia. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196253 | PubMed |
| 23836977 | Aldosterone receptor antagonists: current perspectives and therapies. | Vasc Health Risk Manag | 2013 | https://conductscience.org/library/papers/23836977 | PubMed |
| 6519150 | Comparison of plasma levels of canrenone and metabolites after base hydrolysis in young and elderly subjects following single and multiple doses of spironolactone. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6519150 | PubMed |
| 2292169 | The effect of respiratory disorders on clinical pharmacokinetic variables. | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2292169 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6519151
GET https://conductscience.org/api/papers/v1/6519151/references?page=2